IL7 and neoplasm: Noteworthy, we assessed the mice organ in the mice treated with 28z /IL-7 CAR-T cells on day 32 after tumor cell injection, CD3 + T cells were the major human cells detected in peripheral blood, bone marrow and spleen (Fig. 5C), supporting the notion that IL-7 promotes CAR-T cell persistence in vivo.